Skip to main content
Premium Trial:

Request an Annual Quote

Sequenom Sells 10 MassArray Systems in Third Quarter

NEW YORK, Oct. 2 – Sequenom said Tuesday it had sold 10 of its MassArrray gene analysis systems to a variety of companies and institutions during the third quarter, bringing the number of systems sold to 48.

San Diego-based Sequenom said in a statement that the new customers include Pfizer, the Department of Molecular and Human Genetics, Baylor College of Medicine, Children's Hospital Boston, the Genome Institute of Singapore, the Institute of Biomedical Sciences, Academia Sinica, and the Partners HealthCare/Harvard Medical School Genotyping Center. 

Sequenom also said that the Sanger Center and the National Institutes of Health have each purchased additional systems. The NIH placed the additional system at its National Institute of Arthritis and Musculoskeletal and Skin Diseases. Five of Sequenom’s customers have multiple systems.

The MassArray system, first commercialized in early 2000, provides a platform for genotyping experiments without the use of fluorescence or other tagging techniques. Instead, the company's technology applies MALDI-TOF mass spectrometry directly to fragments of DNA to detect SNPs.  

Sequenom did not say how much the systems sold for, but in the past the company has said that the price of the MassArray is between $400,000 and $1.1 million, depending on consumables. 

In addition, Sequenom said that sales of its SpectroChip high-density launching pads were up 28 percent compared with the previous quarter. 

The Scan

Genetic Testing Approach Explores Origins of Blastocyst Aneuploidy

Investigators in AJHG distinguish between aneuploidy events related to meiotic missegregation in haploid cells and those involving post-zygotic mitotic errors and mosaicism.

Study Looks at Parent Uncertainties After Children's Severe Combined Immunodeficiency Diagnoses

A qualitative study in EJHG looks at personal, practical, scientific, and existential uncertainties in parents as their children go through SCID diagnoses, treatment, and post-treatment stages.

Antimicrobial Resistance Study Highlights Key Protein Domains

By screening diverse versions of an outer membrane porin protein in Vibrio cholerae, researchers in PLOS Genetics flagged protein domain regions influencing antimicrobial resistance.

Latent HIV Found in White Blood Cells of Individuals on Long-Term Treatments

Researchers in Nature Microbiology find HIV genetic material in monocyte white blood cells and in macrophages that differentiated from them in individuals on HIV-suppressive treatment.